BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 11679939)

  • 1. Chromosomal aberrations in a series of large-cell neuroendocrine carcinomas: unexpected divergence from small-cell carcinoma of the lung.
    Ullmann R; Petzmann S; Sharma A; Cagle PT; Popper HH
    Hum Pathol; 2001 Oct; 32(10):1059-63. PubMed ID: 11679939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of loss of heterozygosity in large cell neuroendocrine carcinomas of the lung and small cell lung carcinomas.
    Takeuchi T; Minami Y; Iijima T; Kameya T; Asamura H; Noguchi M
    Pathol Int; 2006 Aug; 56(8):434-9. PubMed ID: 16872437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization.
    Walch AK; Zitzelsberger HF; Aubele MM; Mattis AE; Bauchinger M; Candidus S; Präuer HW; Werner M; Höfler H
    Am J Pathol; 1998 Oct; 153(4):1089-98. PubMed ID: 9777940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic alterations in early-stage pulmonary large cell neuroendocrine carcinoma.
    Hiroshima K; Iyoda A; Shibuya K; Haga Y; Toyozaki T; Iizasa T; Nakayama T; Fujisawa T; Ohwada H
    Cancer; 2004 Mar; 100(6):1190-8. PubMed ID: 15022286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-grade neuroendocrine carcinoma of the lung: comparative clinicopathological study of large cell neuroendocrine carcinoma and small cell lung carcinoma.
    Sun L; Sakurai S; Sano T; Hironaka M; Kawashima O; Nakajima T
    Pathol Int; 2009 Aug; 59(8):522-9. PubMed ID: 19627535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
    Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
    Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinicopathological study of peripheral, small-sized high-grade neuroendocrine tumours of the lung: differences between small-cell lung carcinoma and large-cell neuroendocrine carcinoma.
    Isaka M; Nakagawa K; Ohde Y; Okumura T; Watanabe R; Ito I; Nakajima T; Kondo H
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):841-6. PubMed ID: 22219429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary large cell neuroendocrine carcinoma: its place in the spectrum of pulmonary carcinoma.
    Iyoda A; Hiroshima K; Nakatani Y; Fujisawa T
    Ann Thorac Surg; 2007 Aug; 84(2):702-7. PubMed ID: 17643676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-grade neuroendocrine carcinomas display unique cytogenetic aberrations.
    Welborn J; Jenks H; Taplett J; Walling P
    Cancer Genet Cytogenet; 2004 Nov; 155(1):33-41. PubMed ID: 15527900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative genomic hybridization of bronchial carcinomas and their metastases].
    Petersen I; Petersen S; Bockmühl U; Schwendel A; Wolf G; Dietel M
    Verh Dtsch Ges Pathol; 1997; 81():297-305. PubMed ID: 9474883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical differential diagnosis between large cell neuroendocrine carcinoma and small cell carcinoma by tissue microarray analysis with a large antibody panel.
    Nitadori J; Ishii G; Tsuta K; Yokose T; Murata Y; Kodama T; Nagai K; Kato H; Ochiai A
    Am J Clin Pathol; 2006 May; 125(5):682-92. PubMed ID: 16707368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large cell neuroendocrine carcinoma of the lung: a comparison with large cell carcinoma with neuroendocrine morphology and small cell carcinoma.
    Peng WX; Sano T; Oyama T; Kawashima O; Nakajima T
    Lung Cancer; 2005 Feb; 47(2):225-33. PubMed ID: 15639721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary large-cell neuroendocrine carcinoma of the parotid gland: immunohistochemical and molecular analysis of two cases.
    Nagao T; Sugano I; Ishida Y; Tajima Y; Munakata S; Asoh A; Yamazaki K; Muto H; Konno A; Kondo Y; Nagao K
    Mod Pathol; 2000 May; 13(5):554-61. PubMed ID: 10824928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unbalanced chromosomal aberrations in neuroendocrine lung tumors as detected by comparative genomic hybridization.
    Ullmann R; Schwendel A; Klemen H; Wolf G; Petersen I; Popper HH
    Hum Pathol; 1998 Oct; 29(10):1145-9. PubMed ID: 9781656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization.
    Ried T; Petersen I; Holtgreve-Grez H; Speicher MR; Schröck E; du Manoir S; Cremer T
    Cancer Res; 1994 Apr; 54(7):1801-6. PubMed ID: 8137295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic aberrations in carcinomas of the uterine corpus.
    Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S
    Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
    Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
    Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant high expression of cytokeratins 7, 8, 18, 19 in pulmonary large cell neuroendocrine carcinomas, compared to small cell lung carcinomas.
    Nagashio R; Sato Y; Matsumoto T; Kageyama T; Satoh Y; Ryuge S; Masuda N; Jiang SX; Okayasu I
    Pathol Int; 2010 Feb; 60(2):71-7. PubMed ID: 20398190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transthoracic needle biopsy in the diagnosis of large-cell neuroendocrine carcinoma of the lung.
    Marmor S; Koren R; Halpern M; Herbert M; Rath-Wolfson L
    Diagn Cytopathol; 2005 Oct; 33(4):238-43. PubMed ID: 16138368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative expansion of structural genomic alterations in the spectrum of neuroendocrine lung carcinomas.
    Gugger M; Burckhardt E; Kappeler A; Hirsiger H; Laissue JA; Mazzucchelli L
    J Pathol; 2002 Apr; 196(4):408-15. PubMed ID: 11920736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.